Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Rabson-Mendenhall/Donohue syndrome is also caused by defects of the insulin receptor gene (INSR), but is more serious than type A IRS.
|
31677333 |
2019 |
Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study postulates that this reflects a common genetic cause, and investigates whether the INSR rs2059806 single nucleotide polymorphism (SNP) (a risk factor for essential hypertension, type 2 diabetes and metabolic syndrome) is also associated with pre-eclampsia.
|
28117222 |
2017 |
Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome.
|
10933564 |
2000 |
Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The polymorphisms PstI and MaeIII of INS, NsiI of INSR and Ala513Pro and Gly972Arg of IRS1 have been associated with metabolic syndrome; moreover, the products of these genes are functionally contiguous during insulin signaling.
|
18716398 |
2009 |
Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Here we conduct an association study between MS and genetic polymorphism of the INSR gene in Yi and Han Chinese.
|
22705438 |
2012 |
Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
To determine the relative ratio of the INSR splice variants, we implemented the PCR-capillary electrophoresis method with adipose tissue samples from two weight-loss-intervention studies, the Kuopio Obesity Surgery study (KOBS, n = 108) and a very low calorie diet (VLCD) intervention (n = 32), and from the population-based Metabolic Syndrome in Men study (METSIM, n = 49).
|
24196191 |
2014 |
Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Identification and Functional Characterization of Two Novel Nonsense Mutations in the β-Subunit of INSR That Cause Severe Insulin Resistance Syndrome.
|
26160152 |
2015 |
Metabolic Syndrome X
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Reported evidence shows that vascular risk factors are associated with AD, particularly in the development of protein aggregation, inflammation, oxidative stress, neuronal dysfunction, and disturbances in signaling pathways, with insulin receptor signaling being a common alteration between MetS and AD.
|
27368351 |
2017 |
Metabolic Syndrome X
|
0.100 |
Biomarker
|
disease |
BEFREE |
Protein tyrosine phosphatase 1B (PTP1B) is implicated as a negative regulator of insulin receptor (IR) signaling and a potential drug target for the treatment of type II diabetes and other associated metabolic syndromes.
|
29186763 |
2017 |
Metabolic Syndrome X
|
0.100 |
Biomarker
|
disease |
BEFREE |
Circulating fetuin-A (FetA) inhibits insulin receptor signaling and activates the toll-like receptor 4 proinflammatory cascade; thus, it may contribute to metabolic syndrome.
|
28858873 |
2017 |
Metabolic Syndrome X
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mitsugumin 53 (MG53 or TRIM72), a striated muscle-specific E3 ligase, promotes ubiquitin-dependent degradation of the insulin receptor and insulin receptor substrate-1 and subsequently induces insulin resistance, resulting in metabolic syndrome and type 2 diabetes mellitus (T2DM).
|
30586741 |
2019 |
Metabolic Syndrome X
|
0.100 |
Biomarker
|
disease |
BEFREE |
Growth factor signaling via insulin receptor (IR) and IGF-1 receptor (IGF1R) plays several important roles in the pathogenesis of metabolic syndrome and diabetes.
|
28646158 |
2017 |
Metabolic Syndrome X
|
0.100 |
Biomarker
|
disease |
BEFREE |
As such, we aim to provide an overview of the physiological and pathophysiological roles of the IR within metabolic syndrome and its related pathologies, including cardiovascular health, gut microflora composition, gastrointestinal tract functioning, polycystic ovarian syndrome, pancreatic cancer, and neurodegenerative disorders.
|
29462993 |
2018 |
Metabolic Syndrome X
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Oral HP<i>β</i>CD/Ang-(1-7) treatment decreased <i>ACE</i> and <i>AT1R</i>, increased <i>ACE2</i> gene expression in the liver, and restored thiobarbituric acid reactive substances (TBARS), catalase (CAT), superoxide dismutase (SOD), insulin receptor substrate (<i>Irs-1</i>), glucose transporter type 4 (<i>GLUT4</i>), and serine/threonine kinase 2 (<i>AKT-2</i>) gene expression in the liver and gastrocnemius muscle improving hepatic function, cholesterol levels, and hyperglycemia in MetS rats.
|
31396301 |
2019 |